BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31918630)

  • 1. Late Rescue Therapy with Cord-Derived Mesenchymal Stromal Cells for Established Lung Injury in Experimental Bronchopulmonary Dysplasia.
    O'Reilly M; Möbius MA; Vadivel A; Ionescu L; Fung M; Eaton F; Greer JJ; Thébaud B
    Stem Cells Dev; 2020 Mar; 29(6):364-371. PubMed ID: 31918630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratracheal administration of mesenchymal stem cell-derived extracellular vesicles reduces lung injuries in a chronic rat model of bronchopulmonary dysplasia.
    Porzionato A; Zaramella P; Dedja A; Guidolin D; Bonadies L; Macchi V; Pozzobon M; Jurga M; Perilongo G; De Caro R; Baraldi E; Muraca M
    Am J Physiol Lung Cell Mol Physiol; 2021 May; 320(5):L688-L704. PubMed ID: 33502939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia.
    Pierro M; Ionescu L; Montemurro T; Vadivel A; Weissmann G; Oudit G; Emery D; Bodiga S; Eaton F; Péault B; Mosca F; Lazzari L; Thébaud B
    Thorax; 2013 May; 68(5):475-84. PubMed ID: 23212278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Alleviate Lung Injury in Rat Model of Bronchopulmonary Dysplasia by Affecting Cell Survival and Angiogenesis.
    You J; Zhou O; Liu J; Zou W; Zhang L; Tian D; Dai J; Luo Z; Liu E; Fu Z; Zou L
    Stem Cells Dev; 2020 Dec; 29(23):1520-1532. PubMed ID: 33040709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal delivery of human umbilical cord Wharton's jelly mesenchymal stromal cells restores lung alveolarization and vascularization in experimental bronchopulmonary dysplasia.
    Moreira A; Winter C; Joy J; Winter L; Jones M; Noronha M; Porter M; Quim K; Corral A; Alayli Y; Seno T; Mustafa S; Hornsby P; Ahuja S
    Stem Cells Transl Med; 2020 Feb; 9(2):221-234. PubMed ID: 31774626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Effects of Bone Marrow-derived Versus Umbilical Cord Tissue Mesenchymal Stem Cells in an Experimental Model of Bronchopulmonary Dysplasia.
    Benny M; Courchia B; Shrager S; Sharma M; Chen P; Duara J; Valasaki K; Bellio MA; Damianos A; Huang J; Zambrano R; Schmidt A; Wu S; Velazquez OC; Hare JM; Khan A; Young KC
    Stem Cells Transl Med; 2022 Mar; 11(2):189-199. PubMed ID: 35298658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Gender on Mesenchymal Stem Cell (MSC) Efficacy in Neonatal Hyperoxia-Induced Lung Injury.
    Sammour I; Somashekar S; Huang J; Batlahally S; Breton M; Valasaki K; Khan A; Wu S; Young KC
    PLoS One; 2016; 11(10):e0164269. PubMed ID: 27711256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consecutive daily administration of intratracheal surfactant and human umbilical cord-derived mesenchymal stem cells attenuates hyperoxia-induced lung injury in neonatal rats.
    Chou HC; Chang CH; Chen CH; Lin W; Chen CM
    Stem Cell Res Ther; 2021 May; 12(1):258. PubMed ID: 33933128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human induced pluripotent stem cell-derived lung progenitor and alveolar epithelial cells attenuate hyperoxia-induced lung injury.
    Shafa M; Ionescu LI; Vadivel A; Collins JJP; Xu L; Zhong S; Kang M; de Caen G; Daneshmand M; Shi J; Fu KZ; Qi A; Wang Y; Ellis J; Stanford WL; Thébaud B
    Cytotherapy; 2018 Jan; 20(1):108-125. PubMed ID: 29056548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6.
    Chaubey S; Thueson S; Ponnalagu D; Alam MA; Gheorghe CP; Aghai Z; Singh H; Bhandari V
    Stem Cell Res Ther; 2018 Jun; 9(1):173. PubMed ID: 29941022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal versus intraperitoneal delivery of human umbilical cord tissue-derived cultured mesenchymal stromal cells in a murine model of neonatal lung injury.
    Liu L; Mao Q; Chu S; Mounayar M; Abdi R; Fodor W; Padbury JF; De Paepe ME
    Am J Pathol; 2014 Dec; 184(12):3344-58. PubMed ID: 25455688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells from different sources show distinct therapeutic effects in hyperoxia-induced bronchopulmonary dysplasia in rats.
    Xie Y; Chen F; Jia L; Chen R; Zhang VW; Zhong X; Wang D
    J Cell Mol Med; 2021 Sep; 25(17):8558-8566. PubMed ID: 34322990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human umbilical cord-derived mesenchymal stem cells protect from hyperoxic lung injury by ameliorating aberrant elastin remodeling in the lung of O
    Hou C; Peng D; Gao L; Tian D; Dai J; Luo Z; Liu E; Chen H; Zou L; Fu Z
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1972-1979. PubMed ID: 29242152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal derived factor-1 mediates the lung regenerative effects of mesenchymal stem cells in a rodent model of bronchopulmonary dysplasia.
    Reiter J; Drummond S; Sammour I; Huang J; Florea V; Dornas P; Hare JM; Rodrigues CO; Young KC
    Respir Res; 2017 Jul; 18(1):137. PubMed ID: 28701189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratracheal transplantation of mesenchymal stem cells simultaneously attenuates both lung and brain injuries in hyperoxic newborn rats.
    Kim YE; Park WS; Sung DK; Ahn SY; Sung SI; Yoo HS; Chang YS
    Pediatr Res; 2016 Sep; 80(3):415-24. PubMed ID: 27064241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell type-dependent variation in paracrine potency determines therapeutic efficacy against neonatal hyperoxic lung injury.
    Ahn SY; Chang YS; Sung DK; Yoo HS; Sung SI; Choi SJ; Park WS
    Cytotherapy; 2015 Aug; 17(8):1025-35. PubMed ID: 25863963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats.
    Chang YS; Oh W; Choi SJ; Sung DK; Kim SY; Choi EY; Kang S; Jin HJ; Yang YS; Park WS
    Cell Transplant; 2009; 18(8):869-86. PubMed ID: 19500472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia.
    Tropea KA; Leder E; Aslam M; Lau AN; Raiser DM; Lee JH; Balasubramaniam V; Fredenburgh LE; Alex Mitsialis S; Kourembanas S; Kim CF
    Am J Physiol Lung Cell Mol Physiol; 2012 May; 302(9):L829-37. PubMed ID: 22328358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal Stem Cells and Formyl Peptide Receptor 2 Activity in Hyperoxia-Induced Lung Injury in Newborn Mice.
    Kim YE; Ahn SY; Sung DK; Chang YS; Park WS
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation.
    Willis GR; Fernandez-Gonzalez A; Anastas J; Vitali SH; Liu X; Ericsson M; Kwong A; Mitsialis SA; Kourembanas S
    Am J Respir Crit Care Med; 2018 Jan; 197(1):104-116. PubMed ID: 28853608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.